{
  "version": "https://jsonfeed.org/version/1.1",
  "title": "Market Manipulation: Short and distort enforcement actions",
  "home_page_url": "https://marketmanipulation.org/cases/technique/short-and-distort/",
  "feed_url": "https://marketmanipulation.org/feeds/technique/short-and-distort.json",
  "description": "The 3 most recent enforcement records tagged short and distort in the Market Manipulation library, each linked to its primary source. Tags are our classification, not the charges.",
  "language": "en-US",
  "items": [
    {
      "id": "https://marketmanipulation.org/cases/sec-gregory-lemelson-lemelson-capital-management-llc-short-and-distort-2022/",
      "url": "https://marketmanipulation.org/cases/sec-gregory-lemelson-lemelson-capital-management-llc-short-and-distort-2022/",
      "external_url": "https://www.sec.gov/enforcement-litigation/litigation-releases/lr-25353",
      "title": "SEC v. Gregory Lemelson, Lemelson Capital Management, LLC, and The Amvona Fund (short and distort, 2022)",
      "summary": "In 2022, the Securities and Exchange Commission obtained a judgment against Gregory Lemelson, Lemelson Capital Management, LLC and The Amvona Fund, alleging conduct this library classifies as short and distort. The release records a civil penalty of $160,000.",
      "date_published": "2022-03-31T00:00:00.000Z",
      "tags": [
        "SEC",
        "short-and-distort"
      ]
    },
    {
      "id": "https://marketmanipulation.org/cases/sec-gregory-lemelson-lemelson-capital-management-llc-short-and-distort-2021/",
      "url": "https://marketmanipulation.org/cases/sec-gregory-lemelson-lemelson-capital-management-llc-short-and-distort-2021/",
      "external_url": "https://www.sec.gov/enforcement-litigation/litigation-releases/lr-25258",
      "title": "SEC v. Gregory Lemelson, Lemelson Capital Management, LLC, and The Amvona Fund (short and distort, 2021)",
      "summary": "In November 2021 the SEC reported that a Boston federal jury had found hedge fund adviser Gregory Lemelson and Lemelson Capital Management liable for fraud, concluding they made false statements about Ligand Pharmaceuticals to push its stock down after taking a short position, for more than $1.3 million in profit. The court was to decide remedies later; The Amvona Fund was a relief defendant.",
      "date_published": "2021-11-08T00:00:00.000Z",
      "tags": [
        "SEC",
        "short-and-distort"
      ]
    },
    {
      "id": "https://marketmanipulation.org/cases/sec-gregory-lemelson-lemelson-capital-management-llc-short-and-distort-2018/",
      "url": "https://marketmanipulation.org/cases/sec-gregory-lemelson-lemelson-capital-management-llc-short-and-distort-2018/",
      "external_url": "https://www.sec.gov/enforcement-litigation/litigation-releases/lr-24267",
      "title": "SEC v. Gregory Lemelson, Lemelson Capital Management, LLC, and The Amvona Fund (short and distort, 2018)",
      "summary": "In September 2018 the SEC sued hedge fund adviser Gregory Lemelson and Lemelson Capital Management over allegedly false statements about Ligand Pharmaceuticals. A Boston jury found them liable on three statements in November 2021, and on 30 March 2022 the court entered a final judgment with a five-year injunction and a $160,000 penalty against Lemelson.",
      "date_published": "2018-09-13T00:00:00.000Z",
      "tags": [
        "SEC",
        "short-and-distort"
      ]
    }
  ]
}